Navigation Links
Amarin to Present at the 10th Annual Needham Healthcare Conference
Date:3/31/2011

MYSTIC, Conn. and DUBLIN, March 31, 2011 /PRNewswire/ -- Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Executive Chairman and Chief Executive Officer, Joseph Zakrzewski, will present at 8:40 a.m. EDT on April, 6, 2011 at the 10th Annual Needham Healthcare Conference in New York City. Additionally, Amarin's President, John Thero, will be available at the conference to respond to questions from investors. A live Webcast of the presentation will be available at the following URL:

http://wsw.com/webcast/needham44/amrn/

About Amarin

Amarin Corporation plc is a clinical-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company's lead product candidate is AMR101, the active ingredient in which is ethyl-EPA (ethyl icosapentate). On November 29, 2010, the Company reported positive, statistically significant top-line results from the MARINE trial, the first of its Phase 3 clinical trials of AMR101. In the MARINE trial, AMR101 was investigated as a treatment for very high triglycerides (>500 mg/dL). AMR101 is presently being investigated in a second Phase 3 clinical trial, the ANCHOR trial, for the treatment of patients on statin therapy with high triglycerides (e200 and <500mg/dL) with mixed dyslipidemia. The MARINE trial was, and the ANCHOR trial currently is, conducted under Special Protocol Assessment (SPA) agreements with the U.S. Food and Drug Administration (FDA). Amarin also has next-generation lipid candidates under evaluation for preclinical development.

Investor Contact Information:
Stephen D. Schultz
Investor Relations and Corporate Communications
Amarin Corporation
In U.S.: +1 (860) 572-4979 x292
investor.relations@amarincorp.com

Lee M. Stern
The Trout Group
In U.S.: +1 (646) 378-2922
lstern@troutgroup.com

Media Contact Information:
David Schull or Martina Schwarzkopf, Ph.D.
Russo Partners
In U.S.: +1 (212) 845-4271 or +1 (212) 845-4292 (office)
+1 (347) 591-8785 (mobile)
david.schull@russopartnersllc.com
martina.schwarzkopf@russopartnersllc.com


'/>"/>
SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amarin Reports Year-End and Q4 2010 Results
2. Amarin to Present at Two Upcoming Investor Conferences
3. Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
4. Amarin Provides 2010 Year-End Review to Shareholders
5. Amarin Announces Successful Completion of Offering of American Depositary Shares
6. Amarin Announces Underwriters Exercise of Over-Allotment Option
7. Amarin Prices Public Offering of American Depositary Shares
8. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
9. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
10. Amarin to Present at UBS Life Sciences Conference
11. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Fla. , Feb. 20, 2017   ... helping physicians diagnose and treat patients with cardiovascular ... provide wireless connectivity for ZywiePro, Zywie,s cardiac remote ... AT&T Control Center . AT&T and ... monitoring for those with the disease. The Internet ...
(Date:2/20/2017)... 20, 2017 Seal Shield LLC ( ... for mobile device management and disinfection, the ElectroClave™, to ... Exhibition in Orlando, Fla. from ... devices have become commonplace in today,s healthcare landscape, but ... of concerns, including the disinfection and tracking of these ...
(Date:2/20/2017)... DUBLIN , Feb. 20, 2017 Research ... Blood Refrigerator and Freezer Market Analysis and Trends - Product (RFID ... - Forecast to 2025" report to their offering. ... The Global RFID Blood ... of around 21.3% from 2015 to 2025. This ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... Today, ... Biscom Document Router (BDR), the first IoT device from Biscom designed to deliver ... Biscom will debut BDR at HIMSS17 and will be conducting demonstrations ...
(Date:2/20/2017)... ... February 20, 2017 , ... Houston dentist ... emergency dental care at his office, Antoine Dental Center. Emergency dentistry encompasses many ... they are at risk for serious complications and often experience severe pain. Not ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... Brands to purchase a new ultrasound-enhanced thrombolysis machine, a state-of-the-art device that breaks ... was facilitated by the Pepin Family Foundation. , “We greatly appreciate this gift ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... in better care, and MEDfx and the Delaware Health Information Network (DHIN) have ... As the nation’s first state-wide health information exchange, DHIN stores and shares real-time ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken ... Stairlift and other Butler products. Ken was impressed with the safety and reliability ... endorse the product on his show. This endorsement by Ken Matthews can be ...
Breaking Medicine News(10 mins):